APOE and Alzheimer disease: Previous studies have examined the ApoE4 by sex interaction, suggesting that female carriers are at higher risk of developing and accelerated AD progression, cognitive impairment, and lower brain volumes than male carriers (Sampedro et al., 2015; Neu et al., 2017; O’Bryant et al., 2022).